# Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

> **NCT07214324** · — · RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 60 (estimated)

## Conditions studied

- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smoldering Multiple Myeloma (SMM)
- Multiple Myeloma (MM)

## Interventions

- **OTHER:** Collection of biological material

## Key facts

- **NCT ID:** NCT07214324
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2025-08-12
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07214324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07214324, "Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07214324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*